Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000732858 | SCV000860854 | uncertain significance | not provided | 2018-04-19 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002352251 | SCV002650746 | likely benign | Cardiovascular phenotype | 2021-05-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003330932 | SCV004038911 | likely benign | not specified | 2023-08-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003965537 | SCV004781511 | likely benign | ABCG8-related disorder | 2023-06-05 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |